Member of the Association of American Physicians
Daniel E. Singer mostly deals with Internal medicine, Atrial fibrillation, Stroke, Warfarin and Cardiology. His work carried out in the field of Internal medicine brings together such families of science as Diabetes mellitus and Endocrinology. His Atrial fibrillation research incorporates themes from Complication, Proportional hazards model and Embolism.
His work deals with themes such as Cardioversion, Aspirin, Heart disease and Hazard ratio, which intersect with Stroke. His studies deal with areas such as Anticoagulant, Anesthesia and Prothrombin time as well as Warfarin. His research integrates issues of Surgery and Cohort study in his study of Risk factor.
Daniel E. Singer mainly focuses on Internal medicine, Atrial fibrillation, Cardiology, Stroke and Warfarin. His study connects Diabetes mellitus and Internal medicine. Daniel E. Singer has included themes like Anticoagulant, Anesthesia, Embolism and Hazard ratio in his Atrial fibrillation study.
His Cardiology study incorporates themes from Framingham Risk Score and Ischemic stroke. The study incorporates disciplines such as Randomized controlled trial, Vitamin K antagonist, Confidence interval, Proportional hazards model and Aspirin in addition to Stroke. His biological study deals with issues like Intensive care medicine, which deal with fields such as Community-acquired pneumonia, Emergency medicine and Clinical trial.
His scientific interests lie mostly in Internal medicine, Atrial fibrillation, Stroke, Cardiology and Warfarin. Rivaroxaban, Heart failure, Risk factor, Quality of life and Cohort study are the subjects of his Internal medicine studies. His biological study spans a wide range of topics, including Clinical trial, Ischemic stroke, Cohort and Hazard ratio.
His Stroke research is multidisciplinary, relying on both Interquartile range, Oral anticoagulation, Confidence interval, Proportional hazards model and Myocardial infarction. His work on Catheter ablation as part of general Cardiology study is frequently linked to Variation, therefore connecting diverse disciplines of science. In his study, Patient satisfaction is strongly linked to Discontinuation, which falls under the umbrella field of Warfarin.
His main research concerns Internal medicine, Atrial fibrillation, Stroke, Cardiology and Warfarin. His Atrial fibrillation research includes themes of Quality of life, Heart failure, Clinical trial and Emergency medicine. His Heart failure research is multidisciplinary, incorporating elements of Cohort study and Ischemic stroke.
His Stroke research focuses on Oral anticoagulation and how it connects with Anticoagulant, Guideline and Stroke risk. Daniel E. Singer works mostly in the field of Cardiology, limiting it down to topics relating to Risk factor and, in certain cases, Atrial flutter and Perioperative, as a part of the same area of interest. His Warfarin study combines topics in areas such as Aspirin and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel;Kenneth W. Mahaffey;Jyotsna Garg;Guohua Pan.
The New England Journal of Medicine (2011)
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Alan S. Go;Elaine M. Hylek;Kathleen A. Phillips;YuChiao Chang.
A prediction rule to identify low-risk patients with community-acquired pneumonia
Michael J. Fine;Thomas E. Auble;Donald M. Yealy;Barbara H. Hanusa.
The New England Journal of Medicine (1997)
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
Singer De;Hughes Ra;Gress Dr.
The New England Journal of Medicine (1990)
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Elaine M Hylek;Alan S Go;Yuchiao Chang;Nancy G Jensvold.
The New England Journal of Medicine (2003)
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Elaine M. Hylek;Daniel E. Singer.
Annals of Internal Medicine (1994)
Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John J. You;Daniel E. Singer;Patricia A. Howard;Deirdre A. Lane.
Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population
Susan Colilla;Ann Crow;William Petkun;Daniel E. Singer.
American Journal of Cardiology (2013)
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Daniel E Singer;Gregory W Albers;James E Dalen;Margaret C Fang.
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
Elaine M. Hylek;Steven J. Skates;Mary A. Sheehan;Daniel E. Singer.
The New England Journal of Medicine (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: